Videos

Video Sourced from AACI

A Follow-Up on EHR to EDC with Sites and Sponsors | Supported by IgniteData

Video Sourced from AACI

AACI CRI: IgniteData Information Session

IgniteData leaders Steve Tolle and Jose Galvez share how IgniteData Archer has grown from its oncology trial beginnings to supporting multiple therapeutic areas worldwide.

They highlight the importance of structured data standards, evolving site workflows, and how new capabilities—like adverse event reporting and medical history—are shaping the future of clinical trials.

Beyond Labs and Vitals: Expanding the Future of Clinical Trial Data

Clinical research is more than data—it’s about the patients who give us the gift of participation. In this video, our Chief Medical Officer, Jose Galvez, reflects on the courage of patients who volunteer for trials, sometimes enduring invasive procedures with no immediate benefit, all to advance science and future cures.

Jose Galvez shares why honoring that gift means using every bit of data to its fullest potential, ensuring accuracy from the lab bench to the regulator’s desk. It’s about keeping focus on the mission: reducing the burden of cancer and other diseases through trusted, data-driven science.

The Gift of Patient Clinical Data Why Our Mission Matters

As trials move forward, capturing tumor size and RECIST measurements consistently is critical for sponsors and regulators. Archer pulls data directly from source systems, preserving chain of custody and ensuring standardized, trusted information reaches regulators unchanged. This gives decision-makers confidence that trial outcomes truly reflect patient impact.

Getting Tumor Clinical Data Right: Why Source Integrity Matters

Our Chief Medical Officer, Jose Galvez, shares his background from the FDA and NIH, and why data standards are so critical for clinical research. He explains how frameworks like FHIR and the USCDI create a baseline of interoperable EHR data—helping sponsors, clinicians, and regulators ensure safety and efficacy decisions are made with trusted, consistent information.

From cardiology trials to oncology studies, standardized measures like heart rate, EKGs, and lab values play a vital role in turning everyday clinical data into reliable evidence for trials.

Standardizing Clinical Data for Safer, Faster Drug Approvals

Dr. Jose Galvez, former FDA executive, joins IgniteData to discuss how the Archer platform is transforming clinical trials by automating EHR to EDC data transfer. In this conversation with Julie McCann, they explore how real-time data, digital protocols, and seamless integration are advancing speed, safety, and site satisfaction in clinical research.

Accelerating Clinical Trials: Dr. Jose Galvez on IgniteData’s Archer

When EHR data flows directly to your EDC, everything speeds up—visibility, queries, go/no-go calls.But medicine resists change. That’s why Ignite partners closely with sponsors and sites to prove reliability and eliminate ambiguity at the source.

Dr. Jose Galvez breaks down why correct mapping matters, and how it fuels ROI and better outcomes.

Enhancing Patient Safety and ROI in Clinical Trials

Clinical trials are still written like manuscripts, and that’s slowing everything down.

From site activation delays to missed patient matches, the lack of machine-readable protocols is holding back progress. Dr. Jose Galvez explains why metadata-tagged, computable protocols are the future, and what it will take to get there.

The Future of Clinical Research and Digital Protocols